Delivery of Engineered BMP2 circRNA via Biomimetic Nanovesicles Enhances Titanium Implant Osseointegration Through Translation‐Controlled Osteogenesis
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202505504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yichen Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Stomatology, Inner Mongolia Medical University, Hohhot, China. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 2, Titanium, Osteogenesis, Osseointegration. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Shaanxi.
Abstract (Originalsprache)
Although mRNA therapy has achieved favorable outcomes, it still faces limitations such as poor stability and short duration of protein expression. In this study, we utilized a covalently closed circular RNA encoding bone morphogenetic protein‐2 (BMP2 circRNA), which exhibits exceptional nuclease resistance and an extended half‐life, thereby enabling sustained and efficient BMP2 protein expression. The BMP2 circRNA was encapsulated into biomimetic nanovesicles (BNVs) derived from bone marrow mesenchymal stem cells (BMSCs) using co‐extrusion technology. These BNVs were then anchored onto the surface of micro‐arc oxidized titanium (Ti‐MAO) implants via polydopamine (PDA) adhesion, constructing a novel local gene delivery system. In vitro experiments confirmed that this system is not only efficiently internalized by cells but also evades lysosomal degradation, facilitating the sustained release of BMP2 protein. This, in turn, significantly promoted osteogenic gene expression and accelerated mineral deposition. Furthermore, in vivo animal studies demonstrated that the functionalized implant markedly enhanced bone regeneration, increasing both bone volume fraction and bone‐to‐implant contact. This study successfully integrated the inherent stability of circRNA with a biomimetic delivery strategy, offering an effective approach for improving implant osseointegration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Stomatology, Inner Mongolia Medical University, Hohhot, China.
- State Key Laboratory of Military Stomatology & National Clinical Research Center For Oral Diseases & Shaanxi Key Laboratory of Oral Diseases, Department of Prosthodontics, School of Stomatology, The Fourth Military Medi…
- The Stomatology Department of Shanxi Provincial People Hospital, Shanxi Medical University, Taiyuan, China.
- Department of Oral and Maxillofacial Surgery, State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center For Oral Diseases, Shaanxi Key Laboratory of Stomatology. Sch…
ORCID-Profile: Zhongshan Wang
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Shaanxi
Zitieren
APA
Li, Y., Guo, Z., Zhao, P., Dong, Y., Yong, M., Li, Q., Kong, L., & Wang, Z. (2026). Delivery of Engineered BMP2 circRNA via Biomimetic Nanovesicles Enhances Titanium Implant Osseointegration Through Translation‐Controlled Osteogenesis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505504
Vancouver
Li Y, Guo Z, Zhao P, Dong Y, Yong M, Li Q, et al. Delivery of Engineered BMP2 circRNA via Biomimetic Nanovesicles Enhances Titanium Implant Osseointegration Through Translation‐Controlled Osteogenesis. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505504
BibTeX
@article{Li2026,
author = {Li, Yichen and Guo, Ziyan and Zhao, Pengyu and Dong, Yan and Yong, Mei and Li, Qi and Kong, Liang and Wang, Zhongshan},
title = {Delivery of Engineered BMP2 circRNA via Biomimetic Nanovesicles Enhances Titanium Implant Osseointegration Through Translation‐Controlled Osteogenesis},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202505504}
}
EUVIMED